UDK: 616.5-004.1:616.15-07:577.15
A. B. Zborovski, N. B. Abramov
НИИ клинической и экспериментальной ревматологии РАМН
Significant decrease of adenine deaminase activity in erythrocytes and increase of adenosine deaminase and adenine deaminase activities together with decrease of AMP-deaminase activity in lymphocytes of patients with systemic scleroderma was discovered after the treatment course. Differences between all degrees of pathological process activity were demonstrated to be significant. Evaluation of activity of the enzymes under investigation promoted more precise diagnostics of the degree of process activity and the control therapy efficiency in patients with systemic scleroderma.
adenosine deaminase, AMP deaminase, adenine deaminase, systemic scleroderma.
Зборовский Александр Борисович, д.м.н., прфессор, заслуженный деятель науки РСФСР, академик РАМН – профессор кафедры госпитальной терапии ВолГМУ, директор ГУ НИИ клинической и экспериментальной ревматологии РАМН, complex@vistcom.ru